Basu R - Search Results

1

Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.

Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Adkins A, et al. Among authors: basu r. Diabetes. 2003 Sep;52(9):2213-20. doi: 10.2337/diabetes.52.9.2213. Diabetes. 2003. PMID: 12941759 Clinical Trial.

2

Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning.

Nielsen MF, Dinneen S, Basu A, Basu R, Alzaid A, Rizza RR. Nielsen MF, et al. Among authors: basu r, basu a. Diabetologia. 1998 Sep;41(9):1064-72. doi: 10.1007/s001250051031. Diabetologia. 1998. PMID: 9754825

3

Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.

Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA. Nielsen MF, et al. Among authors: basu r. Diabetes. 1998 Nov;47(11):1735-47. doi: 10.2337/diabetes.47.11.1735. Diabetes. 1998. PMID: 9792543 Free article.

4

Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

Basu R, Basu A, Nielsen M, Shah P, Rizza RA. Basu R, et al. Among authors: basu a. J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9. doi: 10.1210/jcem.84.7.5860. J Clin Endocrinol Metab. 1999. PMID: 10404795

5

Impact of lack of suppression of glucagon on glucose tolerance in humans.

Shah P, Basu A, Basu R, Rizza R. Shah P, et al. Among authors: basu r, basu a. Am J Physiol. 1999 Aug;277(2):E283-90. doi: 10.1152/ajpendo.1999.277.2.E283. Am J Physiol. 1999. PMID: 10444424

6

Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.

Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Basu A, et al. Among authors: basu r. Diabetes. 2000 Feb;49(2):272-83. doi: 10.2337/diabetes.49.2.272. Diabetes. 2000. PMID: 10868944

7

Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.

Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Vella A, et al. Among authors: basu r, basu a. Diabetes. 2000 Apr;49(4):611-7. doi: 10.2337/diabetes.49.4.611. Diabetes. 2000. PMID: 10871199 Clinical Trial.

8

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Shah P, et al. Among authors: basu r, basu a. J Clin Endocrinol Metab. 2000 Nov;85(11):4053-9. doi: 10.1210/jcem.85.11.6993. J Clin Endocrinol Metab. 2000. PMID: 11095432

9

Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.

Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Vella A, et al. Among authors: basu r, basu a. Diabetes. 2001 Mar;50(3):565-72. doi: 10.2337/diabetes.50.3.565. Diabetes. 2001. PMID: 11246876

10

Systemic and regional free fatty acid metabolism in type 2 diabetes.

Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Basu A, et al. Among authors: basu r. Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E1000-6. doi: 10.1152/ajpendo.2001.280.6.E1000. Am J Physiol Endocrinol Metab. 2001. PMID: 11350782 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

869 results

Search Page

Filters